Lundbeck Companies
Lundbeck is a pharmaceutical company that develops products to treat people with psychiatric and neurological disorders.
Acquisitions Number:
Made Acquisitions
Headquarters:
Valby, Hovedstaden, Denmark
Funding Status:
IPO
Employee Number:
5001-10000
Estimated Revenue:
$500M to $1B
Investment Stage:
Undisclosed
Last Funding Type:
Grant
Number Of Exists:
1
Technology:
Health Care, Health Diagnostics, Medical
Investor Type:
Not Classified
Last Funding Date:
2020-03-04
Investors Number:
1.0
Founded Date:
2000-01-01
Industry:
Neurodegenerative disease diagnosis and treatment